Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.86 EUR | +0.81% | +0.63% | +1.50% |
25/06 | Orion Obtains License to Market Navamedic's Parkinson's Disease Drug in Europe | MT |
24/06 | Navamedic ASA and Orion Corporation Sign License & Supply Agreement for Flexilev in Europe | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.50% | 5.99B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- ORNBV Stock
- News Orion Oyj
- Transcript : Orion Oyj, Nine Months 2021 Earnings Call, Oct 20, 2021